Interleukin-1 receptor antagonist restores homeostatic function and limits multiorgan damage in heatstroke

Kun Hung Shen, Chen Kuei Chang, Mao Tsun Lin, Ching Ping Chang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We attempt to investigate whether interleukin-1 receptor antagonist (IL-1ra) therapy improves survival during heatstroke by attenuating multiorgan dysfunction. Anesthetized rabbits, immediately after the onset of heatstroke, are divided into three major groups and given: nothing, normal saline (1 ml/kg, i.v.), or IL-1ra (200-400 μg per 1 ml/kg, i.v.). They are exposed to ambient temperature of 40°C to induce heatstroke. Another group of rabbits is exposed to room temperature (24°C) and used as normothermic controls. Hyperthermia, hypotension, cerebral ischemia and edema, hepatic and renal failure, increased levels of both nitric oxide metabolites (NOx -) and dihydroxybenzoic acid (DHBA) in plasma, hyperkalemia, respiratory alkalosis, and metabolic acidosis and hypoxia are all observed in vehicle-treated heatstroke animals. When the vehicle-treated animals undergo heat stress, their survival time values are found to be 12-18 min. Resuscitation with IL-1ra dose-dependently improves survival time (duration, 132-303 min). As compared with vehicle-treated heatstroke rabbits, IL-1ra therapy significantly causes attenuation of heatstroke-induced hyperthermia, hypotension, cerebral ischemia and edema, intracranial hypertension, hepatic and renal dysfunction, NOx- and DHBA overproduction, hyperkalemia, hypoxia, respiratory alkalosis, and metabolic acidosis. The results indicate that IL-1ra therapy may restore tissue blood flow and homeostatic function, and limit multiorgan dysfunction and death in heatstroke.

Original languageEnglish
Pages (from-to)561-568
Number of pages8
JournalEuropean Journal of Applied Physiology
Volume103
Issue number5
DOIs
Publication statusPublished - Jul 2008

Fingerprint

Heat Stroke
Interleukin-1 Receptors
Respiratory Alkalosis
Respiratory Acidosis
Hyperkalemia
Brain Edema
Rabbits
Acidosis
Brain Ischemia
Controlled Hypotension
Induced Hyperthermia
Temperature
Acids
Intracranial Hypertension
Liver Failure
Resuscitation
Hypotension
Renal Insufficiency
Nitric Oxide
Fever

Keywords

  • Acidosis
  • Heatstroke
  • Hyperkalemia
  • Interleukin-1 receptor antagonist
  • Multiorgan dysfunction

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Physiology
  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Interleukin-1 receptor antagonist restores homeostatic function and limits multiorgan damage in heatstroke. / Shen, Kun Hung; Chang, Chen Kuei; Lin, Mao Tsun; Chang, Ching Ping.

In: European Journal of Applied Physiology, Vol. 103, No. 5, 07.2008, p. 561-568.

Research output: Contribution to journalArticle

@article{35fefec6e4bf42a890dd45f725b211bd,
title = "Interleukin-1 receptor antagonist restores homeostatic function and limits multiorgan damage in heatstroke",
abstract = "We attempt to investigate whether interleukin-1 receptor antagonist (IL-1ra) therapy improves survival during heatstroke by attenuating multiorgan dysfunction. Anesthetized rabbits, immediately after the onset of heatstroke, are divided into three major groups and given: nothing, normal saline (1 ml/kg, i.v.), or IL-1ra (200-400 μg per 1 ml/kg, i.v.). They are exposed to ambient temperature of 40°C to induce heatstroke. Another group of rabbits is exposed to room temperature (24°C) and used as normothermic controls. Hyperthermia, hypotension, cerebral ischemia and edema, hepatic and renal failure, increased levels of both nitric oxide metabolites (NOx -) and dihydroxybenzoic acid (DHBA) in plasma, hyperkalemia, respiratory alkalosis, and metabolic acidosis and hypoxia are all observed in vehicle-treated heatstroke animals. When the vehicle-treated animals undergo heat stress, their survival time values are found to be 12-18 min. Resuscitation with IL-1ra dose-dependently improves survival time (duration, 132-303 min). As compared with vehicle-treated heatstroke rabbits, IL-1ra therapy significantly causes attenuation of heatstroke-induced hyperthermia, hypotension, cerebral ischemia and edema, intracranial hypertension, hepatic and renal dysfunction, NOx- and DHBA overproduction, hyperkalemia, hypoxia, respiratory alkalosis, and metabolic acidosis. The results indicate that IL-1ra therapy may restore tissue blood flow and homeostatic function, and limit multiorgan dysfunction and death in heatstroke.",
keywords = "Acidosis, Heatstroke, Hyperkalemia, Interleukin-1 receptor antagonist, Multiorgan dysfunction",
author = "Shen, {Kun Hung} and Chang, {Chen Kuei} and Lin, {Mao Tsun} and Chang, {Ching Ping}",
year = "2008",
month = "7",
doi = "10.1007/s00421-008-0755-1",
language = "English",
volume = "103",
pages = "561--568",
journal = "European Journal of Applied Physiology",
issn = "1439-6319",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Interleukin-1 receptor antagonist restores homeostatic function and limits multiorgan damage in heatstroke

AU - Shen, Kun Hung

AU - Chang, Chen Kuei

AU - Lin, Mao Tsun

AU - Chang, Ching Ping

PY - 2008/7

Y1 - 2008/7

N2 - We attempt to investigate whether interleukin-1 receptor antagonist (IL-1ra) therapy improves survival during heatstroke by attenuating multiorgan dysfunction. Anesthetized rabbits, immediately after the onset of heatstroke, are divided into three major groups and given: nothing, normal saline (1 ml/kg, i.v.), or IL-1ra (200-400 μg per 1 ml/kg, i.v.). They are exposed to ambient temperature of 40°C to induce heatstroke. Another group of rabbits is exposed to room temperature (24°C) and used as normothermic controls. Hyperthermia, hypotension, cerebral ischemia and edema, hepatic and renal failure, increased levels of both nitric oxide metabolites (NOx -) and dihydroxybenzoic acid (DHBA) in plasma, hyperkalemia, respiratory alkalosis, and metabolic acidosis and hypoxia are all observed in vehicle-treated heatstroke animals. When the vehicle-treated animals undergo heat stress, their survival time values are found to be 12-18 min. Resuscitation with IL-1ra dose-dependently improves survival time (duration, 132-303 min). As compared with vehicle-treated heatstroke rabbits, IL-1ra therapy significantly causes attenuation of heatstroke-induced hyperthermia, hypotension, cerebral ischemia and edema, intracranial hypertension, hepatic and renal dysfunction, NOx- and DHBA overproduction, hyperkalemia, hypoxia, respiratory alkalosis, and metabolic acidosis. The results indicate that IL-1ra therapy may restore tissue blood flow and homeostatic function, and limit multiorgan dysfunction and death in heatstroke.

AB - We attempt to investigate whether interleukin-1 receptor antagonist (IL-1ra) therapy improves survival during heatstroke by attenuating multiorgan dysfunction. Anesthetized rabbits, immediately after the onset of heatstroke, are divided into three major groups and given: nothing, normal saline (1 ml/kg, i.v.), or IL-1ra (200-400 μg per 1 ml/kg, i.v.). They are exposed to ambient temperature of 40°C to induce heatstroke. Another group of rabbits is exposed to room temperature (24°C) and used as normothermic controls. Hyperthermia, hypotension, cerebral ischemia and edema, hepatic and renal failure, increased levels of both nitric oxide metabolites (NOx -) and dihydroxybenzoic acid (DHBA) in plasma, hyperkalemia, respiratory alkalosis, and metabolic acidosis and hypoxia are all observed in vehicle-treated heatstroke animals. When the vehicle-treated animals undergo heat stress, their survival time values are found to be 12-18 min. Resuscitation with IL-1ra dose-dependently improves survival time (duration, 132-303 min). As compared with vehicle-treated heatstroke rabbits, IL-1ra therapy significantly causes attenuation of heatstroke-induced hyperthermia, hypotension, cerebral ischemia and edema, intracranial hypertension, hepatic and renal dysfunction, NOx- and DHBA overproduction, hyperkalemia, hypoxia, respiratory alkalosis, and metabolic acidosis. The results indicate that IL-1ra therapy may restore tissue blood flow and homeostatic function, and limit multiorgan dysfunction and death in heatstroke.

KW - Acidosis

KW - Heatstroke

KW - Hyperkalemia

KW - Interleukin-1 receptor antagonist

KW - Multiorgan dysfunction

UR - http://www.scopus.com/inward/record.url?scp=44249089021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44249089021&partnerID=8YFLogxK

U2 - 10.1007/s00421-008-0755-1

DO - 10.1007/s00421-008-0755-1

M3 - Article

VL - 103

SP - 561

EP - 568

JO - European Journal of Applied Physiology

JF - European Journal of Applied Physiology

SN - 1439-6319

IS - 5

ER -